To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Remifentanil on Post-Operative Analgesic Consumption Following Shoulder Arthroplasty

Download
Share
Reprints
Cite This
About
+ Favorites
Download
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
October 2022

Remifentanil on Post-Operative Analgesic Consumption Following Shoulder Arthroplasty

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Effect of remifentanil on post-operative analgesic consumption in patients undergoing shoulder arthroplasty after interscalene brachial plexus block: a randomized controlled trial

J Anesth . 2022 Aug;36(4):506-513.

Contributing Authors:
Y Kim H Bae S Yoo SK Park YJ Lim S Sakura JT Kim

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Sixty-eight patients undergoing arthroscopic repair for rotator cuff tears with an interscalene brachial plexus block were randomized to receive either remifentanil intraoperatively (n=34) or no analgesics intraoperatively (n=34). The primary outcome of this trial was the dose of fentanyl-nefopam IV-PCA postoperatively over 24 hours. Secondary outcomes such as the amount of rescue analgesics, tota...

Join the Conversation

Please Login or Join to leave comments.